Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion type Assertion NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_head.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion description "[Building on prior work in immune deviation and with PPAR agonists, we have demonstrated that PPARalpha agonists can alter the cytokine phenotype of myelin-reactive T cells, alter their encephalitogenicity, and be useful in the treatment of EAE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_provenance.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion evidence source_evidence_literature NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_provenance.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion SIO_000772 16484546 NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_provenance.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion wasDerivedFrom befree-20140225 NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_provenance.
- NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_assertion wasGeneratedBy ECO_0000203 NP338263.RACCuHIFJ6Rw2sSPskpVzVPVrBGVrpUTfJw6w8BGtVSg8130_provenance.